AbbVie Inc.

NYSE-ABBV

OverviewFinancialsInvestor RelationsEstimatesOwnershipIndustryDividendsModelingFilings

Income Statement	Dec '14	Dec '15	Dec '16	Dec '17	Dec '18	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23	LTM
Total Revenues						33,266	45,804	56,197	58,054	54,318	55,000
Total Revenues % Chg.						1.6%	37.7%	22.7%	3.3%	-6.4%	-1.8%
Cost of Goods Sold, Total						7,439	15,257	17,314	16,527	16,726	16,687
Gross Profit						25,827	30,547	38,883	41,527	37,592	38,313
Selling General & Admin Expenses, Total						6,763	9,867	11,872	12,084	12,904	13,134
R&D Expenses						5,377	6,003	6,820	6,487	7,038	7,405
Other Operating Expenses		—	—	—		-560	—	432	-1	-10	169
Other Operating Expenses, Total						11,580	15,870	19,124	18,570	19,932	20,708
Operating Income						14,247	14,677	19,759	22,957	17,660	17,605
Interest Expense, Total						-1,784	-2,454	-2,423	-2,230	-2,224	-2,505
Interest And Investment Income						275	174	39	186	540	770
Net Interest Expenses						-1,509	-2,280	-2,384	-2,044	-1,684	-1,735
Currency Exchange Gains (Loss)						-42	-71	-51	-148	-146	-79
Other Non Operating Income (Expenses)						9	113	55	142	190	188
EBT, Excl. Unusual Items						12,705	12,439	17,379	20,907	16,020	15,979
Restructuring Charges	—		—	—	—	—	—	—	—	—	—
Merger & Related Restructuring Charges			—	—	—	-103	-1,912	-587	-768	-119	-509
Gain (Loss) On Sale Of Investments	—		—		—	—	—	—	—	—	—
Gain (Loss) On Sale Of Assets	—	—	—	—	—	330	—	—	172	—	—
Asset Writedown		—				-1,030	—	—	-876	-4,230	-3,600
In Process R&D Expenses						-385	-1,376	-1,124	-697	-778	-1,449
Legal Settlements	—		—	—	—	—	—	—	-2,500	485	485
Other Unusual Items	—				—	-3,091	-5,753	-2,679	-2,761	-5,128	-3,840
EBT, Incl. Unusual Items						8,426	3,398	12,989	13,477	6,250	7,066
Income Tax Expense						544	-1,224	1,440	1,632	1,377	1,716
Earnings From Continuing Operations						7,882	4,622	11,549	11,845	4,873	5,350
Minority Interest	—	—	—	—	—	—	-6	-7	-9	-10	-11
Net Income						7,882	4,616	11,542	11,836	4,863	5,339
Preferred Dividend and Other Adjustments						40	60	74	54	43	41
Net Income to Common Incl Extra Items						7,842	4,556	11,468	11,782	4,820	5,298
Net Income to Common Excl. Extra Items						7,842	4,556	11,468	11,782	4,820	5,298
Total Shares Outstanding						1,478.9	1,765.1	1,768.3	1,769.2	1,765.9	1,765.9
Weighted Avg. Shares Outstanding						1,481	1,667	1,770	1,771	1,768	1,768.5
Weighted Avg. Shares Outstanding Dil						1,484	1,673	1,777	1,778	1,773	1,772.5
EPS						5.3	2.7	6.5	6.7	2.7	3
EPS Diluted						5.3	2.7	6.5	6.6	2.7	3
EBITDA						16,264	21,148	28,280	31,424	26,358	26,121
Effective Tax Rate						6.5%	-36%	11.1%	12.1%	22%	24.3%